Comprehensive mobile app to support diet, nutrition, and activity for people with cancer
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
This project will test whether a smartphone app called RestoreMe can help people receiving curative-intent radiation for certain cancers use healthier diet, nutrition, and activity habits during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Montefiore Medical Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (The Bronx, New York) |
| Trial ID | NCT06860425 on ClinicalTrials.gov |
What this trial studies
Adults with specified invasive cancers who are planned for or receiving curative-intent radiation therapy will download and use the RestoreMe mobile application during their treatment course. The app delivers educational content, messaging, and tracking tools for diet, nutrition, and physical activity while usage and engagement are recorded. The study focuses on whether patients consistently use the app throughout treatment and whether it changes patient behaviors and understanding about health. Participants must have a smartphone, read and write English, and meet ECOG performance status 0–2, while metastatic or palliative patients are excluded.
Who should consider this trial
Good fit: Ideal candidates are adults with invasive brain, head and neck, lung, breast, prostate, gastrointestinal, or gynecologic cancers planned for or receiving curative-intent radiation who have a smartphone, read/write English, and have ECOG 0–2.
Not a fit: Patients with metastatic disease, those receiving only palliative treatment, people without a compatible smartphone or who cannot read English, and patients with poorly controlled diabetes are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the app could help patients maintain healthier nutrition and activity habits during radiation therapy and improve their overall treatment experience and recovery.
How similar studies have performed: Previous m-health work, including an RCT of an AI pain-monitoring app in oncology that reduced pain and hospitalizations, shows mobile apps can be effective, though apps specifically targeting diet and activity in curative-intent radiation are less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of invasive malignancy of the brain, head and neck region, lung, breast (DCIS and invasive disease allowed), prostate, gastrointestinal system or gynecological region * Planned to receive, or have received, radiation therapy treatment with curative intent * Note: Patients undergoing systemic therapy are eligible * Note: Any dose/fractionation of curative-intent radiation therapy is eligible * Patients must have a smartphone or other device with the ability to receive text messages, download and use mobile applications * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Ability to read and write in English * Provide written informed consent to participate in the study o NOTE: Patients enrolled on another clinical trial are eligible Exclusion Criteria: * Metastatic cancer * Undergoing treatment with palliative intent * Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL despite attempts to improve glucose control by fasting duration and adjustment of medications) * Uncontrolled hypertension * Any medical condition requiring fluid restriction or nutrient restrictions
Where this trial is running
The Bronx, New York
- Montefiore Einstein Comprehensive Cancer Center — The Bronx, New York, United States (Recruiting)
Study contacts
- Principal investigator: Rafi Kabarriti, MD — Montefiore Medical Center
- Study coordinator: Rafi Kabarriti, MD
- Email: rkabarri@montefiore.org
- Phone: 914-629-7743
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.